Literature DB >> 18791771

Case report: Patella baja after retrograde femoral nail insertion.

James C Krieg1, Amer Mirza.   

Abstract

Patella baja is a rare condition that can result from conditions involving trauma around the knee. Risk factors are believed to include scar tissue formation in the retropatellar fat pad, extensor mechanism dysfunction, and immobilization in extension. Early recognition and aggressive treatment are critical components in minimizing long-term disability. We present a case report of a woman with a fracture of the femoral diaphysis who underwent retrograde placement of an intramedullary nail. Subsequent followup revealed development of patella baja with resultant disability. The diagnosis was made late and the treatment was ineffective. Although patella baja has been reported in trauma around the knee, causative factors include retrograde femoral nailing. We believe early recognition and institution of treatment are important.

Entities:  

Mesh:

Year:  2008        PMID: 18791771      PMCID: PMC2628525          DOI: 10.1007/s11999-008-0501-3

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  40 in total

Review 1.  Reflex sympathetic dystrophy, patella infera contracture syndrome, and loss of motion following anterior cruciate ligament surgery.

Authors:  B R Bach; E M Wojtys; T N Lindenfeld
Journal:  Instr Course Lect       Date:  1997

2.  Patella infera following arthroscopic anterior cruciate ligament reconstruction.

Authors:  J M Chase; W L Hennrikus; T R Cullison
Journal:  Contemp Orthop       Date:  1994-06

3.  Early diagnosis and treatment of developmental patella infera syndrome.

Authors:  L C Almekinders
Journal:  Clin Orthop Relat Res       Date:  1993-03       Impact factor: 4.176

4.  A new surgical procedure for the treatment of patella infera.

Authors:  P P Mariani
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  1994       Impact factor: 4.342

5.  Retrograde nailing of the femur using an intercondylar approach.

Authors:  D Herscovici; K W Whiteman
Journal:  Clin Orthop Relat Res       Date:  1996-11       Impact factor: 4.176

6.  Classification and management of arthrofibrosis of the knee after anterior cruciate ligament reconstruction.

Authors:  K D Shelbourne; D V Patel; D J Martini
Journal:  Am J Sports Med       Date:  1996 Nov-Dec       Impact factor: 6.202

7.  Retrograde intramedullary nailing, without reaming, of fractures of the femoral shaft in multiply injured patients.

Authors:  B R Moed; J T Watson
Journal:  J Bone Joint Surg Am       Date:  1995-10       Impact factor: 5.284

8.  Patellar tendon length change after anterior cruciate ligament reconstruction using the midthird patellar tendon.

Authors:  B S Shaffer; J E Tibone
Journal:  Am J Sports Med       Date:  1993 May-Jun       Impact factor: 6.202

9.  Infrapatellar contracture syndrome. Diagnosis, treatment, and long-term followup.

Authors:  L E Paulos; D C Wnorowski; A E Greenwald
Journal:  Am J Sports Med       Date:  1994 Jul-Aug       Impact factor: 6.202

10.  Patella baja after displacement of tibial tuberosity for patellofemoral disorders.

Authors:  N Sakai; T Koshino; R Okamoto
Journal:  Bull Hosp Jt Dis       Date:  1993
View more
  3 in total

1.  A new reference line in diagnosing a high-riding patella on routine digital lateral radiographs of the knee.

Authors:  Dinko Nizić; Marijana Pervan; Božidar Kovačević
Journal:  Skeletal Radiol       Date:  2014-02-26       Impact factor: 2.199

2.  Current concepts of leg lengthening.

Authors:  Carol C Hasler; Andreas H Krieg
Journal:  J Child Orthop       Date:  2012-03-21       Impact factor: 1.548

3.  Patella baja after intramedullary nailing of tibial fractures, using an infrapatellar/transtendinous approach, predicts worse patient reported outcome.

Authors:  Tilman Graulich; Julius Gerhardy; Tarek Omar Pacha; Marcus Örgel; Christian Macke; Christian Krettek; Mohamed Omar; Emmanouil Liodakis
Journal:  Eur J Trauma Emerg Surg       Date:  2021-11-02       Impact factor: 2.374

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.